Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tullis Health Investors is a commercial-stage healthcare investment manager based in Palm Beach Gardens, Florida. Founded in 1986, the firm has established itself as a key player in the healthcare investment space, focusing on high-growth, scalable companies in sectors such as medical devices, healthcare technology, specialty pharmaceuticals, and biotechnology. The firm manages approximately $150 million in assets across nine private funds, demonstrating a commitment to investing in innovative healthcare solutions.
Over the years, Tullis Health Investors has built a strong portfolio of 17 companies, including notable exits such as Genoptix, Inc., Adams Respiratory Therapeutics, Inc., and Atritech, Inc. These successful exits highlight the firm’s ability to identify and nurture companies that can achieve significant market impact. The firm’s investment strategy emphasizes minimizing exposure to regulatory and technology development risks, allowing them to focus on companies with novel and differentiated healthcare technologies that address large addressable markets.
With a team of 10 professionals, Tullis Health Investors leverages its extensive industry expertise and network to support the growth and scalability of its portfolio companies. The firm’s strategic guidance and operational support have proven invaluable in enhancing the market reach and operational efficiency of its investments.
Tullis Health Investors specializes in investing in commercial-stage healthcare companies, primarily focusing on sectors such as medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology. The firm’s investment strategy is centered around identifying high-growth companies that can scale rapidly and have a significant impact on global health. Tullis Health Investors seeks to invest in innovative healthcare technologies and services that minimize regulatory and technology development risks.
The firm typically targets companies with large addressable markets and emphasizes the importance of novel and differentiated technologies. Their investment approach is designed to support companies that are not only financially viable but also capable of making a substantial contribution to improving healthcare outcomes. Tullis Health Investors is particularly interested in companies that demonstrate the potential for rapid scalability and significant market penetration.
Tullis Health Investors has backed a diverse range of companies within the healthcare sector, showcasing its commitment to innovative solutions. Notable current portfolio companies include:
Additionally, Tullis Health Investors has successfully exited investments in several prominent companies:
These investments reflect Tullis Health Investors' strategic focus on companies that are positioned to make a significant impact in the healthcare industry.
John Tullis: Managing Partner with extensive experience in healthcare investments and a strong track record in identifying high-growth companies.
Jim Tullis: Founding Partner who has played a pivotal role in establishing the firm’s investment strategy and portfolio development.
Barbara Bierer, MD: Venture Partner with a background in medicine and healthcare, contributing expertise in clinical development and regulatory affairs.
Steven Gindi: Chief Financial Officer responsible for overseeing financial operations and fund management.
David Leffell, MD: Venture Partner with significant experience in healthcare investments and clinical practice, providing valuable insights into medical technologies.
Pat Miles: Venture Partner with a focus on strategic growth and operational efficiency within portfolio companies.
Tina Nova, PhD: Venture Partner with expertise in biotechnology and pharmaceuticals, enhancing the firm’s investment capabilities in these sectors.
Darlene Franzé: Vice President of Administration, managing administrative functions and supporting operational activities.
Melanie Oldeman: Vice President of Investor Communications, responsible for maintaining relationships with investors and stakeholders.
Naseer Robinson: Fund Controller overseeing financial reporting and compliance.
Julia Mende: Investment Associate involved in deal sourcing and due diligence processes.
To pitch to Tullis Health Investors, founders should send their business plans via email to deals@tullisfunds.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and financial projections. Founders should expect a response within a few weeks, although timelines may vary based on the volume of inquiries.
Warm introductions are preferred, as they can enhance the likelihood of receiving a timely response. The firm values detailed and well-structured pitches that clearly articulate the startup's vision and potential impact in the healthcare sector.
In recent months, Tullis Health Investors has continued to strengthen its position in the healthcare investment space. The firm has successfully exited investments in several notable companies, including Genoptix, Inc., which was acquired by Novartis, and Adams Respiratory Therapeutics, Inc., acquired by Reckitt Benckiser. These exits underscore the firm’s ability to identify and support high-potential companies within the healthcare sector.
Additionally, Tullis Health Investors has been actively involved in expanding its portfolio, focusing on innovative healthcare technologies that address significant market needs. The firm’s commitment to minimizing regulatory risks and supporting scalable companies remains a cornerstone of its investment strategy.
What are Tullis Health Investors' investment criteria?
Tullis Health Investors focuses on commercial-stage healthcare companies that demonstrate high growth potential and scalability. They prioritize investments in medical devices, healthcare technology, specialty pharmaceuticals, and biotechnology sectors.
How can I apply or pitch to Tullis Health Investors?
Founders can pitch their business ideas by emailing their business plans to deals@tullisfunds.com. It is advisable to include a detailed overview of the business model, market opportunity, and financial projections in the pitch.
What makes Tullis Health Investors different from other VC firms?
The firm emphasizes minimizing regulatory and technology development risks, which allows them to focus on innovative healthcare technologies with large addressable markets. Their extensive industry expertise and network provide significant value to portfolio companies.
What is the geographic scope of Tullis Health Investors?
Tullis Health Investors primarily focuses on the North American healthcare market, although they have also shown interest in opportunities in Asia.
What is the typical fund size and check size for Tullis Health Investors?
The firm manages approximately $150 million across nine private funds, with check sizes varying based on the specific investment opportunity and company stage.
What kind of post-investment involvement does Tullis Health Investors have?
Tullis Health Investors actively engages with its portfolio companies, providing strategic guidance, operational support, and facilitating connections within the healthcare ecosystem to enhance growth and scalability.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.